Elsevier

Journal of Hepatology

Volume 13, Issue 1, July 1991, Pages 128-131
Journal of Hepatology

Regular paper
Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM): Clinical characterization from idiopathic LKM-positive disorders

https://doi.org/10.1016/0168-8278(91)90874-BGet rights and content

Abstract

This study was carried out on 33 patients who were sero-positive for liver-kidney microsomal antibodies (LKM) in order to examine clinical features and the presence of underlying hepatitis C virus infection. Twenty-four sera were positive for antibodies against HCV (anti-HCV) as detected by enzyme immunoassay and confirmed by recombinant immunoblot assay. These patients had chronic liver disease and the majority of those treated with interferon responded favourably. Three of the nine anti-HCV-negative patients had idiopathic chronic hepatitis and two responded favourably to steroids. Two patients were diagnosed as having toxic hepatitis and the other four had various extrahepatic disorders without evidence of liver involvement. The immunoblotting analysis showed reactivity with a 50 kDa microsomal protein which presumably corresponded to cytochrome P-450 db1 both in anti-HCV-positive and -negative sera. In addition a few anti-HCV-positive sera also reacted with a 35 kDa microsomal antigen. Autoimmune markers different from LKM were absent in both groups. The high prevalence of antibodies to the hepatitis C virus among LKM-positive sera confirms that this infection plays a role in forms of chronic hepatitis that had previously been labelled autoimmune. In patients with LKM the presence of anti-HCV may help to forecast a therapeutic response to interferon, while its absence may forecast response to steroid therapy.

References (15)

There are more references available in the full text version of this article.

Cited by (93)

  • New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis

    2006, Cellular Immunology
    Citation Excerpt :

    Moreover, when the recombinant forms of the mitochondrial proteins are used diagnostically, a positive test for AMA is virtually diagnostic of PBC, or at least suggests that the person is at substantial risk of developing PBC over the next 5–10 years [9]. Although AMA is considered the humoral hallmark of PBC, antibodies against various mitochondrial enzymes can be frequently detected in patients with infectious liver diseases [10–17]. However, these AMA responses are not directed at the same epitope as found in patients with PBC and has led to significant misunderstandings regarding the specificity of the AMA response.

  • Autoantibodies in Autoimmune Liver Disease

    2005, Advances in Clinical Chemistry
    Citation Excerpt :

    Homologies have been recognized between epitopes on the CYP2D6 molecule and the genome of the hepatitis C virus (HCV) [14, 15, 78–81]. The detection of anti‐LKM1 in occasional adults [16, 20, 82–84] and children [85] with chronic hepatitis C in Europe (≤10%) may reflect this molecular mimicry and antibody cross‐reactivity. The hexameric amino acid sequence spanning 193–212 of the CYP2D6 molecule is homologous to the sequence spanning region 2985–2990 of the HCV genome and identical to the sequence spanning region 130–135 of the cytomegalovirus (CMV) genome [80].

  • Infection, Autoimmunity and Autoimmune Liver Diseases

    2004, Infection and Autoimmunity, 2nd edition
View all citing articles on Scopus
View full text